Thoughtful editorial in Journal of Clinical Oncology on the #PRESTO trial
🔵High risk BCR (PSA-DT <9m) post-RP and SRT
🟡1yr of ADT vs ADT+Apa vs ADT+Apa+Abi
🟢 Apa delays PSA progression by 5 months, abi added no benefit. 18% gr3+ Htn

Conclusion 👇🏽

ascopubs.org/doi/full/10.12…

Piet Ost Shankar Siva Vérane Achard Thomas Zilli Alfonso Gomez-Iturriaga Dr. Antonio J. Conde CRIG GZA Ziekenhuizen Department of Human Structure and Repair UGent Geneeskunde & Gezondheidswetenschappen Matthias Guckenberger Congratulations!! Very well deserved!

RCT QOL study - HDR vs LDR prostate boost
Faster GU recovery w HDR, LDR w GI issues for longer
Both w reasonable toxicities and much less than seen in ASCENDE...technique matters!
redjournal.org/article/S0360-…

Thoughts?
Piet Ost Thomas Zilli Alison Tree 💙🇺🇦 Vedang Murthy Pierre Blanchard, MD Sean McBride Amar Kishan Daniel E Spratt Alfonso Gomez-Iturriaga Simon Spohn Constantinos Zamboglou Vérane Achard Stefano Arcangeli
Felipe Couñago PhD
Nick James
Dr. Andrew Loblaw

¿Estas interesada en hacer tu residencia en Clínica Universidad de Navarra?
Te esperamos el próximo lunes y martes en nuestra jornada de puertas abiertas. Ven a conocernos!!!

Sean McBride Paul Sargos Piet Ost Thomas Zilli Alison Tree 💙🇺🇦 Pierre Blanchard, MD Amar Kishan Daniel E Spratt Alfonso Gomez-Iturriaga Simon Spohn Constantinos Zamboglou Vérane Achard Stefano Arcangeli Felipe Couñago PhD Nick James Dr. Andrew Loblaw Important update. 5-yr ADT free survival of 64% with so little RT toxicity! That's huge value for patients. 😊

'WPRTzumab' helps 2/3 pts avoid ADT toxicity 😁

A STORM is Brewing. Watch out at #ESTRO2024

✳️ “El cáncer de próstata es el más común entre los hombres de Euskadi. Cuando se detecta a tiempo se cura en el 90% de los casos”

🥼 Alfonso Gómez Iturriaga, óncólogo radioterápico

🏥 OSI EEC - Hospital Universitario Cruces IIS Biobizkaia

📰 El Correo
elcorreo.com/sociedad/salud…

1/ For #KidneyCancerAwareness month The Lancet Oncology has a 50-day full link to TROG Cancer Research FASTRACK II! authors.elsevier.com/a/1ifvZ5EIIgPd…. Thank you Cancer Australia, ANZUP, Varian. A new #radiotherapy standard of care option for inoperable primary #kidneycancer #radonc

Our meta-analysis evaluating impact of ARSI therapy for #prostatecancer on falls & fractures 🦴 finally out in European Urology Oncology

Link: authors.elsevier.com/sd/article/S25…

Craig Jones Struan Gray Mick Brown 🇮🇳 Bhavan Rai 🇬🇧

GU Cancer Research group Division of Cancer Sciences

La nueva generación contra el cáncer: Arkaitz Carracedo ArkaitzCarracedoLAB y Asis Palazon

Puedes leer el artículo completo en El Correo
🔗 ow.ly/46Xe50QoIk2

📣Registration for #ESTRO24 is OPEN! Explore cutting-edge science in #radonc with educational sessions, research presentations, and state-of-the-art lectures. Join us!
ℹ️ Info & registration: bit.ly/3TyvmAo #Radonc #medphys #RTT #medicalphysics

Originally a discussion in a congress with tombal , now a perspective article in Prostate Cancer and Prostatic Diseases about how #EMBARK trial results disrupt held beliefs and may change our way of building future trials 🧐💡
Stephen Freedland, MD 👏
nature.com/articles/s4139…

We made it! Today we completed accrual for the SABR-COMET-10 trial!

As far as I know, it's the first phase III oligomets trial to complete accrual.

A few thoughts below... 🧵

Now online IJROBP - The Red Journal Early results of the randomized Hope trial. Is ultra-HypoRT to the pelvis post prostate BT as well tolerated as conventional RT? sciencedirect.com/science/articl…
Alfonso Gomez-Iturriaga Dr Kevin Martell Dr Stanley Liu

New article (Vol. 190)

Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approach
A. Gomez-Iturriaga et al.

doi.org/10.1016/j.rado…

thegreenjournal.com/article/S0167-…

🆕Introducing the EuroBrachytherapy #Fellowship : an excellent opportunity to learn and gain hands on experience in a radiation oncology subspecialty.
An initiative of the GEC-ESTRO education task force.
👉 Apply here: bit.ly/49YyviB
#Brachytherapy #radonc

Hoy se ha celebrado la primera reunión de la iniciativa ENCOMPASS, grupo internacional de centros de Europa, América y Oceanía para establecer la mayor base de datos global del cáncer de próstata y braquiterapia. El primer proyecto: boost con Braquiterapia. La braquiterapia cura!

Kick-off meeting of the ENCOMPASS initiative to build and analyze an international database of #ProstateCancer #brachytherapy .

First project: brachy boost.

Very motivated group, looking forward to the real work!

If interested, please DM me, Joel Poder or Mario Terlizzi

Martes 14: 2ª edición del curso multidisciplinar de #cancerdeprostata avanzado. Hospital Universitario Marqués de Valdecilla.
No os lo perdáis!

Inscripción:
hvvaldecilla.es/formacion/cu42…

Incredible findings at #ESMO23 : Prostate radiotherapy significantly reduces the long-term risk of obstructive uropathy in #mHSPC . This supports the use of radiotherapy in men at risk of upper urinary tract obstruction. Presented by Craig Jones > bit.ly/3SqZXPR Rashid K. Sayyid